Canopy Growth (NASDAQ:CGC – Get Free Report) is projected to announce its Q2 2027 results before the market opens on Friday, November 6th. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $57.72 million for the quarter. Parties can check the company’s upcoming Q2 2027 earnings overview page for the latest details on the call scheduled for Friday, November 6, 2026 at 10:00 AM ET.
Canopy Growth (NASDAQ:CGC – Get Free Report) last posted its quarterly earnings results on Friday, August 7th. The company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.02. The business had revenue of $142.62 million for the quarter, compared to analysts’ expectations of $58.21 million. Canopy Growth had a negative net margin of 65.33% and a negative return on equity of 21.91%. On average, analysts expect Canopy Growth to post ($0.10) EPS for the current fiscal year and ($0.07) EPS for the next fiscal year.
Canopy Growth Stock Up 3.8%
CGC opened at $0.71 on Wednesday. The business’s fifty day moving average is $0.86 and its two-hundred day moving average is $1.00. The company has a debt-to-equity ratio of 0.31, a quick ratio of 2.39 and a current ratio of 3.04. The company has a market cap of $317.52 million, a price-to-earnings ratio of -1.57 and a beta of 0.87. Canopy Growth has a one year low of $0.64 and a one year high of $2.38.
Analyst Ratings Changes
CGC has been the subject of several analyst reports. Weiss Ratings downgraded Canopy Growth from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, October 16th. Wall Street Zen downgraded Canopy Growth from a “hold” rating to a “sell” rating in a research note on Saturday, October 17th. Two research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Canopy Growth has an average rating of “Hold”.
About Canopy Growth
Canopy Growth Corporation is a cannabis company headquartered in Smiths Falls, Ontario, Canada. Founded in 2013, the company operates in the production, distribution and sale of cannabis and cannabis-related products for adult-use and medical markets.
Its product portfolio includes dried cannabis flower, pre-rolls, cannabis oils, softgels, vapes, beverages and edibles. Canopy Growth markets products under several brands, including Tweed, 7ACRES, Doja and Deep Space, with offerings designed for different consumer preferences and product segments.
Canopy Growth primarily serves the Canadian recreational and medical cannabis markets and has pursued international opportunities in selected medical-cannabis markets.
Further Reading
- Five stocks we like better than Canopy Growth
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.
